Protecting Patient Access to Integrated GI Care in the Independent Setting

In an age when quality of care, cost-effectiveness and transparency are more important than ever, data demonstrates that high-quality, integrated care delivered in the independent medical practice setting is worthy of protection as an alternative to care that is often more costly when furnished in the hospital setting.

November 30, 2020

DHPA Opposes Most Favored Nation Rule Announced by CMS

The MFN Rule could dramatically restrict patient access to infusion medications administered in physician offices, especially for patients with Crohn’s disease and ulcerative colitis, which are both major categories of inflammatory bowel disease (IBD).
Continue Reading >>

October 16, 2020

Step Therapy Can Lead to Higher OOP Costs for Crohn’s Disease Patients (Avalere)

Avalere assessed potential implications of step therapy on patients with employer coverage to examine total OOP and payer costs. Step therapy—also known as “fail first”—is a common form of utilization management that health plans use to control costs. Step therapy requires patients to try a preferred drug before gaining access to the drug prescribed by […]
Continue Reading >>

July 14, 2020

Physicians, Patients Give Telehealth High Marks During COVID-19 Pandemic

Washington DC – A study in Clinical Gastroenterology and Hepatology suggests that telehealth services are an effective way to treat patients safely during periods of health care system disruption and shows that both patients and gastroenterology (GI) physicians overwhelmingly approve of telehealth services provided during the COVID-19 pandemic.
Continue Reading >>

June 8, 2020

Ending Social Injustice and Health Care Disparities

Racism and bigotry are incompatible with the oaths and moral responsibilities that we, as physicians, accepted in dedicating our lives to protecting the health of everyone in our communities, regardless of race, religion, age, gender, nationality or sexual orientation.
Continue Reading >>

December 31, 2019

DHPA Submits Comments on CMS, HHS-OIG Proposed Rules on Stark Law and Anti-Kickback Statute

DHPA today submitted comments on the proposed rules issued by the Centers for Medicare & Medicaid Services (CMS) and the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) to modernize and clarify the federal physician self-referral (Stark) law and the federal Anti-Kickback Statute (AKS).
Continue Reading >>